(MedPage Today) -- African Americans with heart failure and reduced left ventricular output may not derive the same benefit from spironolactone as other ethnic groups, a post-hoc analysis of the randomized RALES trial found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/08/race-tied-to-outcomes-with-hf-drug-cmece.html
No comments:
Post a Comment